Top 10 Key Players in the South Korea Pleurisy Market | Companies & Insights 2026

Top 10 Key Players in the South Korea Pleurisy Market

The South Korea Pleurisy Market is influenced by a combination of local pharmaceutical companies, each making a considerable impact on the growth of the market through their robust R&D, manufacturing strengths, and focus on affordable generics. Major players in the market include Yuhan Corporation, Hanmi Pharmaceutical Co., Ltd., and Chong Kun Dang (CKD) Pharmaceutical.

South Korea Pleurisy Market Overview

According to 6Wresearch, the market for Pleurisy in South Korea is expected to rise, driven by an increase in the occurrence of respiratory infections, pneumonia, and tuberculosis, along with a rise in the awareness of the benefits of early intervention as a treatment. Pleurisy is known as an inflammation of the pleura, which is the membranes surrounding the lungs.

The market is driven by the growing elderly population, improved accessibility of healthcare, and the growing awareness of chronic diseases, which include respiratory ailments. Furthermore, the increase in healthcare expenditure, as well as the government's support for the drug industry, is expected to be beneficial for the market's growth.

Competitive Landscape

The competitive landscape of the South Korea Pleurisy industry is dominated by drug manufacturers with a strong market presence, as well as domestic companies that offer cost-effective products. The market players have managed to establish themselves in the market with the help of quality products, and R&D for new forms of anti-inflammatory and antibiotic treatments.

Below is a list of leading players operating in the South Korea Pleurisy Market:

1. Samjin Pharmaceutical Co., Ltd.

Samjin Pharmaceutical is a prominent Korean drug manufacturer that provides high-quality anti-inflammatory and analgesic formulations used in treating pleuritic pain.

2. Hanmi Pharmaceutical Co., Ltd.

Hanmi Pharmaceutical produces a variety of essential medicines, including advanced antibiotics and respiratory treatments, utilizing advanced production facilities.

3. JW Pharmaceutical

JW Pharmaceutical specializes in the development of ethical drugs and has a strong presence in the market for hospital-grade injectable treatments.

4. Yuhan Corporation

Yuhan Corporation is one of the most respected pharmaceutical firms, offering a wide range of prescription medicines including respiratory health agents.

5. Daewoong Pharmaceutical Co., Ltd.

Daewoong Pharmaceutical is a global healthcare group that manufactures and distributes treatments for pulmonary conditions while focusing on innovative drug delivery systems.

6. Boryung Pharmaceutical

Boryung focuses on various therapeutic areas, including respiratory and infectious diseases, providing reliable antibiotic and anti-inflammatory tablets.

7. Huons Co., Ltd.

Huons is a diversified healthcare company that produces finished pharmaceutical products, including essential treatments for managing chest pain and inflammation.

8. Chong Kun Dang (CKD) Pharm

CKD Pharm is a leader in the pharmaceutical industry, known for its strong manufacturing capabilities in treatments for respiratory-related infections.

9. Dong-A ST Co., Ltd.

Dong-A ST focuses on ethical drugs and has built a significant market presence by providing essential medications for pleurisy to hospitals.

10. GC Biopharma

GC Biopharma maintains a diverse portfolio of specialty medicines and vaccines to address various inflammatory and infectious conditions.

Top 10 Key Players in the South Korea Pleurisy Market: FAQs